Vaccine adjuvants: mechanisms and platforms
T Zhao, Y Cai, Y Jiang, X He, Y Wei, Y Yu… - Signal transduction and …, 2023 - nature.com
Adjuvants are indispensable components of vaccines. Despite being widely used in
vaccines, their action mechanisms are not yet clear. With a greater understanding of the …
vaccines, their action mechanisms are not yet clear. With a greater understanding of the …
The mRNA vaccine revolution: COVID-19 has launched the future of vaccinology
During the COVID-19 pandemic, mRNA (mRNA) vaccines emerged as leading vaccine
candidates in a record time. Nonreplicating mRNA (NRM) and self-amplifying mRNA (SAM) …
candidates in a record time. Nonreplicating mRNA (NRM) and self-amplifying mRNA (SAM) …
Nanoparticle vaccines against infectious diseases
R Pati, M Shevtsov, A Sonawane - Frontiers in immunology, 2018 - frontiersin.org
Due to emergence of new variants of pathogenic micro-organisms the treatment and
immunization of infectious diseases have become a great challenge in the past few years. In …
immunization of infectious diseases have become a great challenge in the past few years. In …
Metal nanoclusters: novel probes for diagnostic and therapeutic applications
Y Tao, M Li, J Ren, X Qu - Chemical Society Reviews, 2015 - pubs.rsc.org
Metal nanoclusters, composed of several to a few hundred metal atoms, have received
worldwide attention due to their extraordinary physical and chemical characteristics …
worldwide attention due to their extraordinary physical and chemical characteristics …
[HTML][HTML] Nanoparticle vaccines
Nanotechnology increasingly plays a significant role in vaccine development. As vaccine
development orientates toward less immunogenic “minimalist” compositions, formulations …
development orientates toward less immunogenic “minimalist” compositions, formulations …
Exosome-based tumor antigens–adjuvant co-delivery utilizing genetically engineered tumor cell-derived exosomes with immunostimulatory CpG DNA
M Morishita, Y Takahashi, A Matsumoto, M Nishikawa… - Biomaterials, 2016 - Elsevier
For cancer immunotherapy via tumor antigen vaccination in combination with an adjuvant,
major challenges include the identification of a particular tumor antigen and efficient delivery …
major challenges include the identification of a particular tumor antigen and efficient delivery …
Smart drug delivery nanocarriers with self‐assembled DNA nanostructures
Self‐assembled DNA nanostructures have emerged as a type of nano‐biomaterials with
precise structures, versatile functions and numerous applications. One particularly promising …
precise structures, versatile functions and numerous applications. One particularly promising …
PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity
Among the emerging subunit vaccines are recombinant protein-and synthetic peptide-based
vaccine formulations. However, proteins and peptides have a low intrinsic immunogenicity …
vaccine formulations. However, proteins and peptides have a low intrinsic immunogenicity …
Advancements in prophylactic and therapeutic nanovaccines
Vaccines activate suitable immune responses to fight against diseases but can possess
limitations such as compromised efficacy and immunogenic responses, poor stability, and …
limitations such as compromised efficacy and immunogenic responses, poor stability, and …
Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations
S Hamdy, A Haddadi, RW Hung… - Advanced drug delivery …, 2011 - Elsevier
Development of safe and effective cancer vaccine formulation is a primary focus in the field
of cancer immunotherapy. The recognition of the crucial role of dendritic cells (DCs) in …
of cancer immunotherapy. The recognition of the crucial role of dendritic cells (DCs) in …